Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

EN TIMMES POSITIVT TRYCKVENTILATION EFTER ETT TRYCKSTÖD PROV MED SPONTANANDNING: EN RANDOMISERAD KLINISK STUDIE

18 september 2026 uppdaterad av: Hospital do Coracao

EN TIMMES POSITIV TRYCKVENTILATION EFTER ETT TRYCKSTÖD FÖR SPONTAN ANDNINGSPRÖVNING: EN RANDOMISERAD KLINISK STUDIE

This is a randomized, open, multicenter, pragmatic, adaptive clinical trial with intention-to-treat analysis. The study will compare two weaning strategies from mechanical ventilation in critically ill patients admitted to intensive care units, with more than 72 hours of mechanical ventilation and with a successful spontaneous breathing trial on pressure support. Immediately after a successful spontaneous breathing trial, eligible patients will be randomized into 2 groups that will be treated according to one of the following interventions:1) One-hour positive pressure ventilation: as soon as the success of the spontaneous breathing trial is confirmed, the patient is submitted to mechanical ventilation for 1 hour using the previous ventilatory parameters and, afterwards, extubated.2) Immediate extubation: the patient is extubated immediately after the success of the spontaneous breathing trial.

Studieöversikt

Detaljerad beskrivning

Adaptive design for sample size. The study will include up to a maximum of 4.000 patients. First interim analysis will be performed after complete data is available for the first 500 eligible patients. The Bayesian logistic regression model will be adjusted to provide posterior probabilities that will be compared with threshold values to evaluate stopping decisions. Extensive simulations were conducted to develop and understand adaptive design performance, interim analysis timing, and decision criteria. The trial may be stopped early for efficacy or futility. Secondary outcomes will be analyzed with a gatekeeping procedure to preserve overall type I error at 0.05. Thus, the assessment of statistical significance of secondary outcomes will be performed only if the preceding outcome in the hierarchy met the threshold for statistical significance. No adjustment for multiple comparisons will be applied for analyses of tertiary outcomes and subgroups. Thus, these results should be interpreted as exploratory.Secondary outcomes tested in hierarchical order will be: (1) Mechanical ventilation free days within 28 days; (2) Hospital free days within 28 days; (3) Mortality within 28 days.

Studietyp

Interventionell

Inskrivning (Beräknad)

4000

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Patients aged > 18 years.
  • Admitted to the intensive care unit (surgical or medical).
  • With endotracheal intubation.
  • Mechanical ventilation for more than 72 hours.
  • Who underwent successful spontaneous breathing trial (according to the study protocol) and is considered able to be extubated.

Exclusion Criteria:

  • Patients unable to obey commands.
  • With non-planned extubation.
  • Neuromuscular disease and cervical spinal cord injury.
  • Tracheostomy.
  • Contraindication for cardiopulmonary resuscitation or reintubation.
  • Terminal extubation.
  • Lack of informed consent.
  • Previously included in the trial.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: En timmes positivt tryckventilation

As soon as the success of the spontaneous breathing trial is confirmed, the patient will be submitted to one-hour positive pressure ventilation using the previous ventilatory parameters and, afterwards, extubated.

Aktiv komparator: Omedelbar extubation

The patient will be extubated immediately (up to 10 minutes) after the success of the spontaneous breathing trial.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Number of Participants With Extubation Failure Within 7 Days
Tidsram: 7 days (from randomization through Day 7 after randomization)

Extubation failure is defined as a composite endpoint of reintubation or death within 7 days after randomization

7 days (from randomization through Day 7 after randomization)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Ventilator-Free Days Through Day 28
Tidsram: 28 days (from randomization through Day 28 after randomization)

Ventilator-free days are defined as the number of days alive and free from invasive mechanical ventilation from randomization through Day 28 after randomization. If a patient dies before day 28, the ventilator-free days will be counted as zero. If a patient is reintubated and returns to mechanical ventilation and later is extubated again and remains in unassisted breathing until day 28, the ventilator-free days will be counted from the end of the last period of assisted breathing until day 28. An invasive mechanical ventilation period of less than 24 hours for surgical purposes will count as 1 ventilator-free day. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from mechanical ventilation for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome.

28 days (from randomization through Day 28 after randomization)
Hospital-Free Days Through Day 28
Tidsram: 28 days (from randomization through Day 28 after randomization)

Hospital-free days are defined as the number of days alive and out of the hospital from randomization through Day 28 after randomization. If a patient dies before day 28, the hospital-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from hospital for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed through day 28 to ascertain this outcome.

28 days (from randomization through Day 28 after randomization)
Number of Participants Who Died Within 28 Days
Tidsram: 28 days (from randomization through Day 28 after randomization)

All-cause mortality from randomization through day 28

28 days (from randomization through Day 28 after randomization)

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Ventilatory Support-Free Days Through Day 28
Tidsram: 28 days (from randomization through Day 28 after randomization)

Ventilatory support-free days are defined as the number of days alive and free from any ventilatory support (invasive or noninvasive) from randomization through day 28. Any use of invasive mechanical ventilation for any duration during a calendar day will count as 1 day with ventilatory support (i.e., not free). Use of noninvasive ventilatory support (noninvasive ventilation or high-flow nasal cannula) for ≥6 hours in any calendar day will count as 1 day with ventilatory support. Participants who die before day 28 will be assigned 0 ventilatory support-free days. If reintubation occurs and the participant later achieves unassisted spontaneous breathing again, ventilatory support-free days will be counted from the end of the last assisted-breathing period through day 28, provided the participant remains alive and free from ventilatory support.

28 days (from randomization through Day 28 after randomization)
Number of Participants With Extubation Failure Within 2 Days
Tidsram: 2 days (from randomization through Day 2 after randomization)

Extubation failure is defined as a composite endpoint of reintubation or death within 2 days after randomization

2 days (from randomization through Day 2 after randomization)
Number of Participants With Death or Reintubation Within 28 Days
Tidsram: 28 days (from randomization through Day 28 after randomization)

Composite endpoint of reintubation or death within 28 days after randomization

28 days (from randomization through Day 28 after randomization)
Intensive Care Unit-Free Days Through Day 28
Tidsram: 28 days (from randomization through Day 28 after randomization)

ICU-free days are defined as the number of days alive and out of the intensive care unit from randomization through day 28. If a patient dies before day 28, the ICU-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered as alive and free from ICU for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome.

28 days (from randomization through Day 28 after randomization)
Number of Participants Who Died in the Hospital
Tidsram: From randomization to hospital discharge, up to 90 days

All-cause mortality occurring from randomization until hospital discharge (death before hospital discharge)

From randomization to hospital discharge, up to 90 days
Number of Participants Who Died in the Intensive Care Unit
Tidsram: From randomization to ICU discharge, up to 90 days

All-cause mortality occurring from randomization until ICU discharge (death before ICU discharge)

From randomization to ICU discharge, up to 90 days

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 januari 2027

Primärt slutförande (Beräknad)

1 december 2029

Avslutad studie (Beräknad)

1 februari 2030

Studieregistreringsdatum

Först inskickad

23 december 2025

Först inskickad som uppfyllde QC-kriterierna

23 december 2025

Första postat (Faktisk)

7 januari 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

22 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

18 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera